Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area
Introduction: Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) typically arises as an autonomic neuropathy primarily affecting small fibres and it occurs in adult patients in their second or third decades of life. It progresses rapidly and can lead to death in approximately 10 years....
Main Authors: | N. Andrés, J.J. Poza, J.F. Martí Massó |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2018-11-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580818301159 |
Similar Items
-
Polineuropatía amiloidótica familiar I por mutación Val50Met (Val30Met) en el gen de la transtiretina
by: N. Andrés, et al.
Published: (2018-11-01) -
Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families.
by: Ole Bernt Suhr, et al.
Published: (2019-01-01) -
Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
by: Ando, Y., et al.
Published: (2022) -
Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden
by: Juan González-Moreno, et al.
Published: (2021-06-01) -
Role of salivary gland biopsy for the diagnosis of symptomatic onset in Transthyretin Val30Met Familial Amyloid Polyneuropathy
by: Rui Pedro de Oliveira Lopes
Published: (2021)